<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T00:06:09Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/178974" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/178974</identifier><datestamp>2025-12-05T10:07:56Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478916</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478929</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition</dc:title>
   <dc:creator>Gómez Valenzuela, Fernán</dc:creator>
   <dc:creator>Escobar, Enrico</dc:creator>
   <dc:creator>Pérez Tomás, Ricardo</dc:creator>
   <dc:creator>Montecinos, Viviana P.</dc:creator>
   <dc:subject>Càncer</dc:subject>
   <dc:subject>Inflamació</dc:subject>
   <dc:subject>Fenotip</dc:subject>
   <dc:subject>Cancer</dc:subject>
   <dc:subject>Inflammation</dc:subject>
   <dc:subject>Phenotype</dc:subject>
   <dcterms:abstract>Microbial infections are a major public health concern. Antimicrobial peptides (AMPs) have been demonstrated to be a plausible alternative to the current arsenal of drugs that has become inefficient due to multidrug resistance. Herein we describe a new AMP family, namely the super-cationic peptide dendrimers (SCPDs). Although all members of the series exert some antibacterial activity, we propose that special attention should be given to (KLK)2KLLKLL-NH2 (G1KLK-L2KL2), which shows selectivity for Gram-negative bacteria and virtually no cytotoxicity in HepG2 and HEK293. These results reinforce the validity of the SCPD family as a valuable class of AMP and support G1KLK-L2KL2 as a strong lead candidate for the future development of an antibacterial agent against Gram-negative bacteria.</dcterms:abstract>
   <dcterms:issued>2021-07-12T09:54:48Z</dcterms:issued>
   <dcterms:issued>2021-07-12T09:54:48Z</dcterms:issued>
   <dcterms:issued>2021-06-10</dcterms:issued>
   <dcterms:issued>2021-07-09T08:27:28Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.3389/fonc.2021.686792</dc:relation>
   <dc:relation>Frontiers in Oncology, 2021, vol. 11, num. 686792</dc:relation>
   <dc:relation>https://doi.org/10.3389/fonc.2021.686792</dc:relation>
   <dc:rights>cc by (c) Gómez Valenzuela, Fernán et al., 2021</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Frontiers Media SA</dc:publisher>
   <dc:source>Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>